FDA Drug Recalls

Recalls / Active ingredient / Memantine Hydrochloride

Memantine Hydrochloride

5 FDA drug recalls involving the active ingredient “Memantine Hydrochloride”.

DateClassProductFirm
2021-03-15Class IINamzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 capsules Rx OnCardinal Health Inc.
2020-04-24Class IIIMemantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, ManufacThe Harvard Drug Group
2020-02-12Class IIMemantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin PLupin Pharmaceuticals Inc.
2019-12-13Class IIIMemantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-count Unit Dose Cartons , Rx only, MaThe Harvard Drug Group
2019-12-10Class IIIMemantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-count bottles (NDC 68180-249-09 andLupin Pharmaceuticals Inc.